Although initial steps have been taken to block viral infections with La inhibitors, the emerging role of La in tumor pathobiology prompted us to develop a novel screening technique that could identify heretofore unknown small compounds are able to inhibit La:RNA interactions. Here, SSB is linked to viral infectious disease.